Insulet Corporation (PODD) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Devices Branche. Der Hauptsitz des Unternehmens ist in Acton, MA, United States. Der aktuelle CEO ist Ashley A. McEvoy.
PODD hat IPO-Datum 2007-05-15, 5,400 Vollzeitbeschäftigte, gelistet an der NASDAQ Global Select, eine Marktkapitalisierung von $14.18B.
Insulet Corporation is a medical device company that develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's flagship product is the Omnipod System, a tubeless, self-adhesive disposable insulin pump worn on the body for up to three days, controlled wirelessly by a handheld personal diabetes manager. Insulet distributes its products through independent distributors, pharmacy channels, and direct sales across the United States, Canada, Europe, the Middle East, and Australia. Founded in 2000 and headquartered in Acton, Massachusetts, the company serves a global market of insulin-dependent diabetes patients seeking convenient, modern insulin delivery solutions.
